The therapeutic effect of sertraline combined with brain function treatment for depressive episodes
Xinzi Guo, Gaifen Zhang, Qianqian Wu, Mo Sun
Abstract
Xinzi Guo, Gaifen Zhang, Qianqian Wu, Mo Sun
Abstract
Objective To observe the therapeutic effect of sertraline combined with brain function treatment instrument for depressive episodes. Methods According to sequence of hospitalization, 80 patients with depression without severe physical disease randomly divided into sertraline with brain function treatment group (40 cases, group A) and only take sertraline group (40 cases, group B), and two groups were given Sertraline 100 mg/day for 8 weeks. 24 Hamilton Depression Scale (HAMD-24) and 20 Self-rating Depression Scale (SDS-20) were assessed before and after 1, 2, 4, 6, 8 weekend treatment. Results The scores of HAMD-24 and SDS-20 were not significant difference between the two groups before treatment(P>0.05), but there were statistically significant after treatment (P<0.05). They were significantly decreased after 8 weeks treatment in group A and were decreased slightly in group B with HAMD-24 and SDS-20.Clinical efficiencies of HAMD of the two groups were 87.2 %, 76.3 %, respectively, and those of SDS were 89.7 %, 78.9 %, respectively. Clinical efficacy in group A was significantly better than that in group B (P<0.05). Conclusion Sertraline with brain function treatment instrument can shorten the onset time and improve its effect. Key words: Depression; Sertraline; Brain function treatment
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the therapeutic effect of sertraline combined with brain function treatment instrument for depressive episodes. Methods According to sequence of hospitalization, 80 patients with depression without severe physical disease randomly divided into sertraline with brain function treatment group (40 cases, group A) and only take sertraline group (40 cases, group B), and two groups were given Sertraline 100 mg/day for 8 weeks. 24 Hamilton Depression Scale (HAMD-24) and 20 Self-rating Depression Scale (SDS-20) were assessed before and after 1, 2, 4, 6, 8 weekend treatment. Results The scores of HAMD-24 and SDS-20 were not significant difference between the two groups before treatment(P>0.05), but there were statistically significant after treatment (P<0.05). They were significantly decreased after 8 weeks treatment in group A and were decreased slightly in group B with HAMD-24 and SDS-20.Clinical efficiencies of HAMD of the two groups were 87.2 %, 76.3 %, respectively, and those of SDS were 89.7 %, 78.9 %, respectively. Clinical efficacy in group A was significantly better than that in group B (P<0.05). Conclusion Sertraline with brain function treatment instrument can shorten the onset time and improve its effect. Key words: Depression; Sertraline; Brain function treatment
Key concepts: Hamd, Sertraline, Depression (economics), Hamilton depression scale, Internal medicine, Medicine, Therapeutic effect, Rating scale